Warren M. Zapol
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Warren M. Zapol has a total of 194 co-authors. Here are the top co-authors by number of shared publications:
Donald B. Bloch
Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston (F.I., D.B.B., W.M.Z.).
11 shared publications- Donald B. Bloch
Center for Immunology and Inflammatory Diseases and the Division of Rheumatology, Allergy, and Immunology of the Department of Medicine, Boston (D.B.B.)
11 shared publications Binglan Yu
Anesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA, 02114
7 shared publications- Rajeev Malhotra
Massachusetts General Hospital and Harvard Medical School
7 shared publications Fumito Ichinose
Anesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
6 shared publicationsLuca Zazzeron
Anesthesia Center for Critical Care Research of the Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital Harvard Medical School Boston Massachusetts USA
6 shared publications
Latest Publications
- 23 November 2021
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (2) , e61-e73
Matrix Gla Protein Levels Are Associated With Arterial Stiffness and Incident Heart Failure With Preserved Ejection Fraction
Objective: Arterial stiffness is a risk factor for cardiovascular disease, including heart failure with preserved ejection fraction (HFpEF). MGP (matrix Gla protein) is implicated in vascular calcification in animal models, and circulating levels of the uncarboxylated, inactive form of MGP (ucMGP) are associated with cardiovascular disease-related and all-cause mortality in human studies. However, the role of MGP in arterial stiffness is uncertain. Approach and Results: We examined the association of ucMGP levels with vascular calcification, arterial stiffness including carotid-femoral pulse wave velocity (PWV), and incident heart failure in community-dwelling adults from the Framingham Heart Study. To further investigate the link between MGP and arterial stiffness, we compared aortic PWV in age- and sex-matched young (4-month-old) and aged (10-month-old) wild-type and Mgp +/− mice. Among 7066 adults, we observed significant associations between higher levels of ucMGP and measures of arterial stiffness, including higher PWV and pulse pressure. Longitudinal analyses demonstrated an association between higher ucMGP levels and future increases in systolic blood pressure and incident HFpEF. Aortic PWV was increased in older, but not young, female Mgp +/− mice compared with wild-type mice, and this augmentation in PWV was associated with increased aortic elastin fiber fragmentation and collagen accumulation. Conclusions: This translational study demonstrates an association between ucMGP levels and arterial stiffness and future HFpEF in a large observational study, findings that are substantiated by experimental studies showing that mice with Mgp heterozygosity develop arterial stiffness. Taken together, these complementary study designs suggest a potential role of therapeutically targeting MGP in HFpEF.
- 23 November 2021
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 42 (2) , e61-e73
Matrix Gla Protein Levels Are Associated With Arterial Stiffness and Incident Heart Failure With Preserved Ejection Fraction
Objective: Arterial stiffness is a risk factor for cardiovascular disease, including heart failure with preserved ejection fraction (HFpEF). MGP (matrix Gla protein) is implicated in vascular calcification in animal models, and circulating levels of the uncarboxylated, inactive form of MGP (ucMGP) are associated with cardiovascular disease-related and all-cause mortality in human studies. However, the role of MGP in arterial stiffness is uncertain. Approach and Results: We examined the association of ucMGP levels with vascular calcification, arterial stiffness including carotid-femoral pulse wave velocity (PWV), and incident heart failure in community-dwelling adults from the Framingham Heart Study. To further investigate the link between MGP and arterial stiffness, we compared aortic PWV in age- and sex-matched young (4-month-old) and aged (10-month-old) wild-type and Mgp +/− mice. Among 7066 adults, we observed significant associations between higher levels of ucMGP and measures of arterial stiffness, including higher PWV and pulse pressure. Longitudinal analyses demonstrated an association between higher ucMGP levels and future increases in systolic blood pressure and incident HFpEF. Aortic PWV was increased in older, but not young, female Mgp +/− mice compared with wild-type mice, and this augmentation in PWV was associated with increased aortic elastin fiber fragmentation and collagen accumulation. Conclusions: This translational study demonstrates an association between ucMGP levels and arterial stiffness and future HFpEF in a large observational study, findings that are substantiated by experimental studies showing that mice with Mgp heterozygosity develop arterial stiffness. Taken together, these complementary study designs suggest a potential role of therapeutically targeting MGP in HFpEF.
- 17 October 2021
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 54 (3) , 426-432
Hyperbaric phototherapy augments blood carbon monoxide removal
Background and Objectives: Carbon monoxide (CO) poisoning is responsible for nearly 50,000 emergency department visits and 1200 deaths per year. Compared to oxygen, CO has a 250‐fold higher affinity for hemoglobin (Hb), resulting in the displacement of oxygen from Hb and impaired oxygen delivery to tissues. Optimal treatment of CO‐poisoned patients involves the administration of hyperbaric 100% oxygen to remove CO from Hb and to restore oxygen delivery. However, hyperbaric chambers are not widely available and this treatment requires transporting a CO‐poisoned patient to a specialized center, which can result in delayed treatment.Visible light is known to dissociate CO from carboxyhemoglobin (COHb). In a previous study, we showed that a system composed of six photo‐extracorporeal membrane oxygenation (ECMO) devices efficiently removes CO from a large animal with CO poisoning. In this study, we tested the hypothesis that the application of hyperbaric oxygen to the photo‐ECMO device would further increase the rate of CO elimination.Study Design/Material and Methods: We developed a hyperbaric photo‐ECMO device and assessed the ability of the device to remove CO from CO‐poisoned human blood. We combined four devices into a “hyperbaric photo‐ECMO system” and compared its ability to remove CO to our previously described photo‐ECMO system, which was composed of six devices ventilated with normobaric oxygen.Results: Under normobaric conditions, an increase in oxygen concentration from 21% to 100% significantly increased CO elimination from CO‐poisoned blood after a single pass through the device. Increased oxygen pressure within the photo‐ECMO device was associated with higher exiting blood PO2 levels and increased CO elimination. The system of four hyperbaric photo‐ECMO devices removed CO from 1 L of CO‐poisoned blood as quickly as the original, normobaric photo‐ECMO system composed of six devices.Conclusion: This study demonstrates the feasibility and efficacy of using a hyperbaric photo‐ECMO system to increase the rate of CO elimination from CO‐poisoned blood. This technology could provide a simple portable emergency device and facilitate immediate treatment of CO‐poisoned patients at or near the site of injury.
- 17 October 2021
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 54 (3) , 426-432
Hyperbaric phototherapy augments blood carbon monoxide removal
Background and Objectives: Carbon monoxide (CO) poisoning is responsible for nearly 50,000 emergency department visits and 1200 deaths per year. Compared to oxygen, CO has a 250‐fold higher affinity for hemoglobin (Hb), resulting in the displacement of oxygen from Hb and impaired oxygen delivery to tissues. Optimal treatment of CO‐poisoned patients involves the administration of hyperbaric 100% oxygen to remove CO from Hb and to restore oxygen delivery. However, hyperbaric chambers are not widely available and this treatment requires transporting a CO‐poisoned patient to a specialized center, which can result in delayed treatment.Visible light is known to dissociate CO from carboxyhemoglobin (COHb). In a previous study, we showed that a system composed of six photo‐extracorporeal membrane oxygenation (ECMO) devices efficiently removes CO from a large animal with CO poisoning. In this study, we tested the hypothesis that the application of hyperbaric oxygen to the photo‐ECMO device would further increase the rate of CO elimination.Study Design/Material and Methods: We developed a hyperbaric photo‐ECMO device and assessed the ability of the device to remove CO from CO‐poisoned human blood. We combined four devices into a “hyperbaric photo‐ECMO system” and compared its ability to remove CO to our previously described photo‐ECMO system, which was composed of six devices ventilated with normobaric oxygen.Results: Under normobaric conditions, an increase in oxygen concentration from 21% to 100% significantly increased CO elimination from CO‐poisoned blood after a single pass through the device. Increased oxygen pressure within the photo‐ECMO device was associated with higher exiting blood PO2 levels and increased CO elimination. The system of four hyperbaric photo‐ECMO devices removed CO from 1 L of CO‐poisoned blood as quickly as the original, normobaric photo‐ECMO system composed of six devices.Conclusion: This study demonstrates the feasibility and efficacy of using a hyperbaric photo‐ECMO system to increase the rate of CO elimination from CO‐poisoned blood. This technology could provide a simple portable emergency device and facilitate immediate treatment of CO‐poisoned patients at or near the site of injury.
- 5 August 2021
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 54 (2) , 256-267
Veno‐venous extracorporeal blood phototherapy increases the rate of carbon monoxide (CO) elimination in CO‐poisoned pigs
Background and objectives: Carbon monoxide (CO) inhalation is the leading cause of poison‐related deaths in the United States. CO binds to hemoglobin (Hb), displaces oxygen, and reduces oxygen delivery to tissues. The optimal treatment for CO poisoning in patients with normal lung function is the administration of hyperbaric oxygen (HBO). However, hyperbaric chambers are only available in medical centers with specialized equipment, resulting in delayed therapy. Visible light dissociates CO from Hb with minimal effect on oxygen binding. In a previous study, we combined a membrane oxygenator with phototherapy at 623 nm to produce a “mini” photo‐ECMO (extracorporeal membrane oxygenation) device, which improved CO elimination and survival in CO‐poisoned rats. The objective of this study was to develop a larger photo‐ECMO device (“maxi” photo‐ECMO) and to test its ability to remove CO from a porcine model of CO poisoning.Study design/materials and methods: The “maxi” photo‐ECMO device and the photo‐ECMO system (six maxi photo‐ECMO devices assembled in parallel), were tested in an in vitro circuit of CO poisoning. To assess the ability of the photo‐ECMO device and the photo‐ECMO system to remove CO from CO‐poisoned blood in vitro, the half‐life of COHb (COHb‐t1/2), as well as the percent COHb reduction in a single blood pass through the device, were assessed. In the in vivo studies, we assessed the COHb‐t1/2 in a CO‐poisoned pig under three conditions: (1) While the pig breathed 100% oxygen through the endotracheal tube; (2) while the pig was connected to the photo‐ECMO system with no light exposure; and (3) while the pig was connected to the photo‐ECMO system, which was exposed to red light.Results: The photo‐ECMO device was able to fully oxygenate the blood after a single pass through the device. Compared to ventilation with 100% oxygen alone, illumination with red light together with 100% oxygen was twice as efficient in removing CO from blood. Changes in gas flow rates did not alter CO elimination in one pass through the device. Increases in irradiance up to 214 mW/cm2 were associated with an increased rate of CO elimination. The photo‐ECMO device was effective over a range of blood flow rates and with higher blood flow rates, more CO was eliminated. A photo‐ECMO system composed of six photo‐ECMO devices removed CO faster from CO‐poisoned blood than a single photo‐ECMO device. In a CO‐poisoned pig, the photo‐ECMO system increased the rate of CO elimination without significantly increasing the animal's body temperature or causing hemodynamic instability.Conclusion: In this study, we developed a photo‐ECMO system and demonstrated its ability to remove CO from CO‐poisoned 45‐kg pigs. Technical modifications of the photo‐ECMO system, including the development of a compact, portable device, will permit treatment of patients with CO poisoning at the scene of their poisoning, during transit to a local emergency room, and in hospitals that lack HBO facilities.
- 5 August 2021
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 54 (2) , 256-267
Veno‐venous extracorporeal blood phototherapy increases the rate of carbon monoxide (CO) elimination in CO‐poisoned pigs
Background and objectives: Carbon monoxide (CO) inhalation is the leading cause of poison‐related deaths in the United States. CO binds to hemoglobin (Hb), displaces oxygen, and reduces oxygen delivery to tissues. The optimal treatment for CO poisoning in patients with normal lung function is the administration of hyperbaric oxygen (HBO). However, hyperbaric chambers are only available in medical centers with specialized equipment, resulting in delayed therapy. Visible light dissociates CO from Hb with minimal effect on oxygen binding. In a previous study, we combined a membrane oxygenator with phototherapy at 623 nm to produce a “mini” photo‐ECMO (extracorporeal membrane oxygenation) device, which improved CO elimination and survival in CO‐poisoned rats. The objective of this study was to develop a larger photo‐ECMO device (“maxi” photo‐ECMO) and to test its ability to remove CO from a porcine model of CO poisoning.Study design/materials and methods: The “maxi” photo‐ECMO device and the photo‐ECMO system (six maxi photo‐ECMO devices assembled in parallel), were tested in an in vitro circuit of CO poisoning. To assess the ability of the photo‐ECMO device and the photo‐ECMO system to remove CO from CO‐poisoned blood in vitro, the half‐life of COHb (COHb‐t1/2), as well as the percent COHb reduction in a single blood pass through the device, were assessed. In the in vivo studies, we assessed the COHb‐t1/2 in a CO‐poisoned pig under three conditions: (1) While the pig breathed 100% oxygen through the endotracheal tube; (2) while the pig was connected to the photo‐ECMO system with no light exposure; and (3) while the pig was connected to the photo‐ECMO system, which was exposed to red light.Results: The photo‐ECMO device was able to fully oxygenate the blood after a single pass through the device. Compared to ventilation with 100% oxygen alone, illumination with red light together with 100% oxygen was twice as efficient in removing CO from blood. Changes in gas flow rates did not alter CO elimination in one pass through the device. Increases in irradiance up to 214 mW/cm2 were associated with an increased rate of CO elimination. The photo‐ECMO device was effective over a range of blood flow rates and with higher blood flow rates, more CO was eliminated. A photo‐ECMO system composed of six photo‐ECMO devices removed CO faster from CO‐poisoned blood than a single photo‐ECMO device. In a CO‐poisoned pig, the photo‐ECMO system increased the rate of CO elimination without significantly increasing the animal's body temperature or causing hemodynamic instability.Conclusion: In this study, we developed a photo‐ECMO system and demonstrated its ability to remove CO from CO‐poisoned 45‐kg pigs. Technical modifications of the photo‐ECMO system, including the development of a compact, portable device, will permit treatment of patients with CO poisoning at the scene of their poisoning, during transit to a local emergency room, and in hospitals that lack HBO facilities.
- 11 March 2021
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 133 (1) , 83-93
Hypoxia ameliorates brain hyperoxia and NAD+ deficiency in a murine model of Leigh syndrome
- 11 March 2021
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 133 (1) , 83-93
Hypoxia ameliorates brain hyperoxia and NAD+ deficiency in a murine model of Leigh syndrome
- Open Access
- 1 February 2021
- Published by Elsevier in Redox Biology
- Vol. 39, 101826
Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia
- 1 February 2021
- Published by Elsevier in Redox Biology
- Vol. 39, 101826
Open AccessAntimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia
- 1 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6524) , 52-57
Airway stem cells sense hypoxia and differentiate into protective solitary neuroendocrine cells
Protecting the lung from hypoxic stress: The lung experiences constantly changing oxygen concentrations and must recognize and respond to a low-oxygen environment. Shivaraju et al. reveal that airway stem cells directly sense hypoxia and respond by differentiating into protective neuroendocrine (NE) cells that secrete a peptide that mitigates tissue damage (see the Perspective by Zacharias). This work suggests that the observed NE cell hyperplasia that accompanies lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease represents a compensatory physiologic response. More broadly, it raises the possibility that stem cells throughout the body sense hypoxia and differentiate into organ-specific NE cells. Science , this issue p. 52 ; see also p. 32
- 1 January 2021
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 371 (6524) , 52-57
Airway stem cells sense hypoxia and differentiate into protective solitary neuroendocrine cells
Protecting the lung from hypoxic stress: The lung experiences constantly changing oxygen concentrations and must recognize and respond to a low-oxygen environment. Shivaraju et al. reveal that airway stem cells directly sense hypoxia and respond by differentiating into protective neuroendocrine (NE) cells that secrete a peptide that mitigates tissue damage (see the Perspective by Zacharias). This work suggests that the observed NE cell hyperplasia that accompanies lung diseases such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease represents a compensatory physiologic response. More broadly, it raises the possibility that stem cells throughout the body sense hypoxia and differentiate into organ-specific NE cells. Science , this issue p. 52 ; see also p. 32
- 9 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (513)
Phototherapy and extracorporeal membrane oxygenation facilitate removal of carbon monoxide in rats
Extracorporeal blood phototherapy increases carbon monoxide elimination in rats and improves survival in animals with associated lung injury.
- 9 October 2019
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 11 (513)
Phototherapy and extracorporeal membrane oxygenation facilitate removal of carbon monoxide in rats
Extracorporeal blood phototherapy increases carbon monoxide elimination in rats and improves survival in animals with associated lung injury.
- 1 October 2019
- Published by Elsevier in Cell Metabolism
- Vol. 30 (4) , 824-832.e3
Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation
- 1 October 2019
- Published by Elsevier in Cell Metabolism
- Vol. 30 (4) , 824-832.e3
Leigh Syndrome Mouse Model Can Be Rescued by Interventions that Normalize Brain Hyperoxia, but Not HIF Activation
- Open Access
- 1 February 2019
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 316 (2) , L391-L399
Impaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome
Hypoxic pulmonary vasoconstriction (HPV) is a physiological vasomotor response that maintains systemic oxygenation by matching perfusion to ventilation during alveolar hypoxia. Although mitochondria appear to play an essential role in HPV, the impact of mitochondrial dysfunction on HPV remains incompletely defined. Mice lacking the mitochondrial complex I (CI) subunit Ndufs4 ( Ndufs4−/−) develop a fatal progressive encephalopathy and serve as a model for Leigh syndrome, the most common mitochondrial disease in children. Breathing normobaric 11% O2 prevents neurological disease and improves survival in Ndufs4−/− mice. In this study, we found that either genetic Ndufs4 deficiency or pharmacological inhibition of CI using piericidin A impaired the ability of left mainstem bronchus occlusion (LMBO) to induce HPV. In mice breathing air, the partial pressure of arterial oxygen during LMBO was lower in Ndufs4−/− and in piericidin A-treated Ndufs4+/+ mice than in respective controls. Impairment of HPV in Ndufs4−/− mice was not a result of nonspecific dysfunction of the pulmonary vascular contractile apparatus or pulmonary inflammation. In Ndufs4-deficient mice, 3 wk of breathing 11% O2 restored HPV in response to LMBO. When compared with Ndufs4−/− mice breathing air, chronic hypoxia improved systemic oxygenation during LMBO. The results of this study show that, when breathing air, mice with a congenital Ndufs4 deficiency or chemically inhibited CI function have impaired HPV. Our study raises the possibility that patients with inborn errors of mitochondrial function may also have defects in HPV.
- 1 February 2019
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 316 (2) , L391-L399
Open AccessImpaired hypoxic pulmonary vasoconstriction in a mouse model of Leigh syndrome
Hypoxic pulmonary vasoconstriction (HPV) is a physiological vasomotor response that maintains systemic oxygenation by matching perfusion to ventilation during alveolar hypoxia. Although mitochondria appear to play an essential role in HPV, the impact of mitochondrial dysfunction on HPV remains incompletely defined. Mice lacking the mitochondrial complex I (CI) subunit Ndufs4 ( Ndufs4−/−) develop a fatal progressive encephalopathy and serve as a model for Leigh syndrome, the most common mitochondrial disease in children. Breathing normobaric 11% O2 prevents neurological disease and improves survival in Ndufs4−/− mice. In this study, we found that either genetic Ndufs4 deficiency or pharmacological inhibition of CI using piericidin A impaired the ability of left mainstem bronchus occlusion (LMBO) to induce HPV. In mice breathing air, the partial pressure of arterial oxygen during LMBO was lower in Ndufs4−/− and in piericidin A-treated Ndufs4+/+ mice than in respective controls. Impairment of HPV in Ndufs4−/− mice was not a result of nonspecific dysfunction of the pulmonary vascular contractile apparatus or pulmonary inflammation. In Ndufs4-deficient mice, 3 wk of breathing 11% O2 restored HPV in response to LMBO. When compared with Ndufs4−/− mice breathing air, chronic hypoxia improved systemic oxygenation during LMBO. The results of this study show that, when breathing air, mice with a congenital Ndufs4 deficiency or chemically inhibited CI function have impaired HPV. Our study raises the possibility that patients with inborn errors of mitochondrial function may also have defects in HPV.